Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,505,897
-$366,318 QoQ
Shares Held
43,580
+3.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#560
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empirical Finance, LLC holds $104,508,931 across 9 Drug Manufacturers - General names. GILD ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,524 | $33,013,114 | |
| 2 | JNJ |
Johnson & Johnson
|
85,199 | $21,637,990 | |
| 3 | ABBV |
AbbVie Inc.
|
61,181 | $15,395,586 | |
| 4 | MRK |
Merck & Co., Inc.
|
93,774 | $12,049,959 | |
| 5 | AMGN |
Amgen Inc
|
18,865 | $6,831,393 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
43,580 | $5,505,897 | |
| 7 | PFE |
Pfizer Inc
|
197,099 | $4,746,143 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
72,834 | $4,196,695 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,505,897 | 43,580 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,872,215 | 42,134 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,180,855 | 42,210 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,892,769 | 44,079 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,841,027 | 43,664 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,861,513 | 43,387 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,948,448 | 42,746 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $3,632,284 | 43,324 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,908,789 | 42,396 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $3,328,992 | 45,447 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,557,959 | 43,920 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,275,552 | 43,709 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $3,028,773 | 39,299 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $2,904,115 | 35,002 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $2,857,946 | 33,290 | Shares | Sole | 2023-02-21 | |
| 2022-09-30 | $1,888,392 | 30,611 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,585,982 | 25,659 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,444,159 | 24,292 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $1,569,828 | 21,620 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,109,427 | 15,883 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,980,000 | 28,754 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,858,371 | 28,754 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,675,208 | 28,754 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,675,798 | 26,520 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $1,511,640 | 19,647 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $1,728,077 | 23,115 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||